Publications 2021

Berge-Seidl V, Pihlstrøm L, Toft M (2021)
Integrative analysis identifies bHLH transcription factors as contributors to Parkinson's disease risk mechanisms
Sci Rep, 11 (1), 3502
DOI 10.1038/s41598-021-83087-2, PubMed 33568722

Publications 2018

Berge-Seidl V, Pihlstrøm L, Wszolek ZK, Ross OA, Toft M (2018)
No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease
Neurobiol Aging, 74, 236.e1-236.e5
DOI 10.1016/j.neurobiolaging.2018.09.022, PubMed 30340792

Pihlstrøm L, Blauwendraat C, Cappelletti C, Berge-Seidl V, Langmyhr M, Henriksen SP, van de Berg WDJ, Gibbs JR, Cookson MR, International Parkinson Disease Genomics Consortium, North American Brain Expression Consortium, Singleton AB, Nalls MA, Toft M (2018)
A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease
Ann Neurol, 84 (1), 117-129
DOI 10.1002/ana.25274, PubMed 30146727

Publications 2017

Berge-Seidl V, Pihlstrøm L, Maple-Grødem J, Forsgren L, Linder J, Larsen JP, Tysnes OB, Toft M (2017)
The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal
Neurosci Lett, 658, 48-52
DOI 10.1016/j.neulet.2017.08.040, PubMed 28830825

Publications 2014

Pihlstrøm L, Berge V, Rengmark A, Toft M (2014)
Parkinson's disease correlates with promoter methylation in the α-synuclein gene
Mov Disord, 30 (4), 577-80
DOI 10.1002/mds.26073, PubMed 25545759

Publications 2010

Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA, Nicoll RA, Edwards RH (2010)
Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis
Neuron, 65 (1), 66-79
DOI 10.1016/j.neuron.2009.12.023, PubMed 20152114